Federal funding could be allocated to pharma company as early as next month
(ZEROHEDGE) – Shares of Moderna are up more than 4% in the New York premarket trading session following a report by the Financial Times that the US government is preparing to “bankroll a late-stage trial of Moderna’s mRNA pandemic bird flu vaccine.” H5N1 is spreading across the US ahead of the November presidential elections, and some prominent doctors have already warned about university labs experimenting with H5N1 gain-of-function. Shares have been ramping higher on bird flu headlines over the past several months.
Sources familiar with the talks between Moderna and the government’s Biomedical Advanced Research and Development Authority, known as Barda, say federal funding could be allocated to the pharma company as early as next month.
Nope…not this time. The govt/establishment has to know compliance on any future vax mandate is going to be minimal at best. I think the plan is to vaccinate use through livestock…get the cows the vax and then have us pick it up through ingestion. Wouldn’t shock me to find out that’s what they’ve been testing, to see how much, if any of the MRNA can be transferred through milk/meat.
New data from the National Institutes of Health reveal the agency and its scientists collected $710 million in royalties during the pandemic, from late 2021 through 2023. These are payments made by private companies, like pharmaceuticals, to license medical innovations from government scientists.
Almost all that cash — $690 million — went to the National Institute of Allergy and Infectious Diseases, the subagency led by Dr. Anthony Fauci, and 260 of its scientists.
Payments skyrocketed during the pandemic era: Those years saw more than double the amount of cash flow to NIH from the private sector, compared to the prior 12 combined. All told, it’s $1.036 billion.
I wouldn’t take another government recommended vaccine for a million bucks.